Skip to main content
Clinical Trials/NCT03355625
NCT03355625
Completed
Not Applicable

Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients

Aarhus University Hospital2 sites in 1 country33 target enrollmentSeptember 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Extracorporeal Membrane Oxygenation
Sponsor
Aarhus University Hospital
Enrollment
33
Locations
2
Primary Endpoint
Changes in platelet function
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The primary aim is to describe platelet function in adult patients treated with extracorporeal membrane oxygenation (ECMO). A clarification of the platelet function in these critically ill patients contributes to an understanding of the mechanisms underlying their coagulopathy.

The present study is a substudy to the study entitled; "Coagulopathy During Extracorporeal Membrane Oxygenation" (pending Clinical Trial ID number).

Detailed Description

The knowledge of platelet function during extracorporeal membrane oxygenation (ECMO) remains sparse. In the present study, the aim is to investigate platelet function in adult patients treated with ECMO using flow cytometry. The investigators hypothesize that platelet function increases from day 1 to day 3 in patients treated with ECMO. The secondary aim is to investigate the association between platelet function and the incidence of bleeding episodes and thrombosis during ECMO treatment. The present study is a substudy to the study entitled; "Coagulopathy During Extracorporeal Membrane Oxygenation" (pending Clinical Trial ID number).

Registry
clinicaltrials.gov
Start Date
September 1, 2017
End Date
November 30, 2019
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Aarhus University Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Treatment with veno-venous or veno-arterial ECMO
  • Age ≥18 years

Exclusion Criteria

  • ECMO treatment initiated post-operatively

Outcomes

Primary Outcomes

Changes in platelet function

Time Frame: Platelet function measured day 1 and day 3 on ECMO

Platelet function on day 3 compared with day 1 on ECMO. Measured by flow cytometry

Secondary Outcomes

  • Changes in platelet aggregation(Platelet function measured every morning from day 1 to day 8 on ECMO (except weekends).)
  • Immature platelet count(Measured every morning from day 1 to day 8 on ECMO (except weekends))
  • Platelet count(Measured every morning from day 1 to day 8 on ECMO (except weekends))

Study Sites (2)

Loading locations...

Similar Trials